![1]()
Article
Rivaroxaban versus warfarin in mild acute ischemic stroke secondary to atrial fibrillation
February 12, 2018
Clinical question: Is rivaroxaban as effective and safe as warfarin immediately following minor acute ischemic stroke from atrial fibrillation?
![1]()
News
Heart attacks bring 12 weeks of higher stroke risk
January 27, 2018
During the 12 weeks following hospitalization for a myocardial infarction, patients had an elevated risk for a new-onset acute ischemic stroke.
![1]()
Video
VIDEO: New stroke guideline embraces imaging-guided thrombectomy
January 25, 2018
The latest U.S. acute ischemic stroke guideline adopts imaging as the main thrombectomy eligibility criterion out to 24 hours after stroke onset.
![1]()
News
Persistent opioid use a risk after surgery in teens and young adults
January 24, 2018
Higher initial opioid requirements didn’t necessarily mean persistent opioid use later.
![1]()
News
NSAIDs reduce spinal pain but are not “clinically important”
January 19, 2018
Are nonsteroidal anti-inflammatory drugs effective at reducing neck and low back pain?
![1]()
News
Thrombectomy shines in presence of a clinical deficit and imaging mismatch
January 3, 2018
Less disability, greater functional independence, and less neurologic deterioration was observed for thrombectomy plus standard care.
![1]()
News
Improvements made in safe opioid prescribing practices but crisis far from over
December 28, 2017
Clinical question: How have national and county-level opioid prescribing practices changed from the years 2006 to 2015?
![1]()
Opinion
Helping patients with addictions get, stay clean
December 13, 2017
Advise patients to consider programs affiliated with major medical centers or established treatment centers, an expert says.
![1]()
News
Acute kidney injury linked with doubled inpatient VTEs
December 8, 2017
TORONTO – Which comes first: the acute kidney injury or the venous thromboembolism?
![1]()
News
Pharmacomechanical thrombolysis does not reduce post-thrombotic syndrome risk
December 6, 2017
The ATTRACT trial results contrast with recent reports from another randomized trial, known as CAVENT.
